Our CEO Randolf Kerschbaumer will attend the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (CICON) in New York and the 4th Macrophage-directed Therapies Summit in Boston. Randolf was invited to present at both meetings to share data on the antitumorigenic and TME-modifying potential of our clinical

Meet our CTO, Alexander Schinagl at the 13th World Bispecific Summit in Boston, US. Alexander will present data on our modular PreTarg-it® platform which utilizes bispecific antibodies for optimized biodelivery of payloads.

Meet our Director Preclinical Development, Christine Landlinger at the WCLC in Vienna, Austria. Be sure to visit Christine’s e-poster on August 8 to learn more about our clinical candidate for the treatment of malignant solid tumors (e-poster EP08.01-015 – Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of

Our Senior Scientist Barbara Maurer will attend the ESMO World Congress on Gastrointestinal Cancer in Barcelona, Spain. Barbara will present data demonstrating antitumorigenic activity and TME modulation of ON203 in patient-derived colorectal cancer tumoroids.

Our Director CMC Biologics, Friedmund Bachmann will attend the 6th Theranostics World Congress in Wiesbaden, Germany. He will present a poster on ON102, our diagnostic radioimmunoconjugate targeting oxMIF.

Meet our Director Preclinical Development, Christine Landlinger & Barbara Maurer, Senior Scientist at the EACR 2022 in Seville, Spain. Be sure to visit Barbara’s poster on ON203 to learn more about our clinical candidate for solid tumor indications.

OncoOne’s CEO, Randolf Kerschbaumer will be present at the BIO2022. Randolf will give a corporate presentation on June 15 at 4:45 PM PDT on our innovative oxMIF-targeting pipeline in oncology & immunology.

Join our Director CMC Biologics, Friedmund Bachmann at the 4th TRPEurope Summit in Amsterdam. Conference participants will have the opportunity to meet Friedmund during a presentation examining ON102, our proprietary radioimmunoconjugate designed to provide a non-invasive approach for diagnostic applications.